Technologies
PDF


WARF: P160072WO01

  • Patent applied for.

Enhanced Endotoxin Detection: New Advantages in Liquid Crystal Assays for Gram-Negative Pathogens


INVENTORS -

Nicholas Abbott, Abhijit Dan

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing an improved system for detecting endotoxins in the presence of masking agents such as buffers or surfactants.
OVERVIEWGram-negative bacterial infections are an ongoing challenge to health care providers worldwide. Detection, treatment and control of such pathogens have gained increasing importance in the context of antimicrobial resistance and emerging infectious disease.

The LAL (Limulus Amoebocyte Lysate) assay, derived from the horseshoe crab, is typically used to detect the presence of Gram-negative bacteria and remains the only FDA-approved approach. While effectively detecting lipopolysaccharides (LPS) or lipid A (endotoxins present on membranes of Gram-negative bacteria) with a high degree of sensitivity, this complex, expensive assay is susceptible to low endotoxin recovery (LER) causing false positive and negative results in the presence of masking agents (e.g., buffers surfactants, cations, proteins, chelating agents and nucleic acids).

UW–Madison researchers previously developed a faster, more sensitive and less expensive method utilizing liquid crystals (LCs). LC droplets in an aqueous solution indicate the presence of endotoxin with a readily observable change in configuration from bipolar (two point defects) to radial (one point defect). This structural change allows for the detection of endotoxins at concentrations as low as 1 picogram per milliliter.
THE INVENTIONUW–Madison researchers have now demonstrated enhanced endotoxin detection in the presence of masking agents in their previous liquid crystal system.

Unlike the LAL assay, the LC-based method does not suffer from LER or any loss of sensitivity due to the presence of cations (e.g., Ca2+ or Mg2+), buffers (e.g., citrate), surfactants (e.g., SDS), chelating agents (e.g., EDTA), proteins or nucleic acids (e.g., DNA or RNA). Thus, the LC-based method provides faster and cheaper detection of endotoxin when compared to existing methods, such as the LAL assay.
APPLICATIONS
  • Detection of endotoxin
  • Diagnosis of septicemia and other infections caused by Gram-negative bacteria
  • Water and food purity testing
  • Pharmaceutical manufacturing
KEY BENEFITS
  • Reduces false readings and interference by other agents (e.g., masking by buffers and surfactants)
  • Increases assay sensitivity
STAGE OF DEVELOPMENTThe development of this technology was supported by the WARF Accelerator Program. The Accelerator Program selects WARF’s most commercially promising technologies and provides expert assistance and funding to enable achievement of commercially significant milestones. WARF believes that these technologies are especially attractive opportunities for licensing.
ADDITIONAL INFORMATION
Publications
  • Carter et al. 2015. Synthetic Mimics of Bacterial Lipid A Trigger Optical Transitions in Liquid Crystal Microdroplets at Ultralow Picogram-per-Milliliter Concentrations. Langmuir. 31, 12850-12855.
  • Miller D. S. and Abbott N. L. 2013. Influence of Droplet Size, pH and Ionic Strength on Endotoxin-Triggered Ordering Transitions in Liquid Crystalline Droplets. Soft Matter. 9, 374-382.
  • Lin I. H., Miller D. S., Bertics P. J., Murphy C. J., de Pablo J. J. and Abbott N. L. 2011. Endotoxin-Induced Structural Transformations in Liquid Crystalline Droplets. Science. 332, 1297-1300.
Contact Information
For current licensing status, please contact Jennifer Gottwald at jennifer@warf.org or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.